Skip to Main Content

Mark A Lemmon, PhD, FRS

David A. Sackler Professor of Pharmacology; Associate Cancer Center Director for Basic Science, Yale Cancer Center; Co-director, Cancer Biology Institute

Contact Information

Mark A Lemmon, PhD, FRS

Office Locations

Mailing Address

  • Pharmacology

    Department of Pharmacology, Yale School of Medicine, B326A Sterling Hall of Medicine

    New Haven, CT, 06520-8066

    United States



Mark Lemmon, PhD was appointed the Co-Director of the Cancer Biology Institute and the David A. Sackler Professor of Pharmacology in 2015. Dr. Lemmon returns to Yale, where he completed his PhD in 1993, from the University of Pennsylvania’s Perelman School of Medicine. At UPenn, he was the George W. Raiziss Professor of Biochemistry and Biophysics as well as Chair of the department and an Investigator at the Abramson Family Cancer Research Institute. Dr. Lemmon’s research focuses on the signaling pathways of receptor tyrosine kinases (RTKs), which, when mutated cause cancers and other diseases.

Education & Training

  • PhD
    Yale University (1993)
  • BA
    Oxford University (Hertford College), Biochemistry (1988)

Departments & Organizations